Results 181 to 190 of about 2,433,822 (346)

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

Molecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche, Renske Imschoot, Béatrice Lintermans, Lode Denolf, Joachim Taminau, Charlotte Fieuws, Geert Berx, Kris Gevaert, Kathleen B. M. Claes   +8 more
wiley   +1 more source

Comparison of CRISPR-Cas9, CRISPR-Cas12f1, and CRISPR-Cas3 in eradicating resistance genes KPC-2 and IMP-4. [PDF]

Microbiol Spectr
Huang J, Ding K, Chen J, Fan J, Huang L, Qiu S, Wang L, Du X, Wang C, Pan H, Yuan Z, Liu H, Song H.   +12 more
europepmc   +1 more source

1P1-N07 Locomotion Control System Analysis Based on Dermatomic Plantar Sensitivity(Musculoskeletal modeling)

, 2013
Akihiko Murai, Yoshihiko Nakamura
openalex   +2 more sources

A DIA‐MS‐based proteomics approach to find potential serum prognostic biomarkers in glioblastoma patients

Molecular Oncology, EarlyView.
A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul, François Guillonneau, Odile Blanchet, Hamza Lasla, Audrey Rousseau, Catherine Guette, Alice Boissard, Cécile Henry, Morgan Dhondt, Pascal Jézéquel, Philippe Menei, Jean‐Michel Lemée   +11 more
wiley   +1 more source

Innovative nucleic acid detection of <i>Clostridioides difficile</i> utilizing the PAM-unconventional, one-step LAMP/CRISPR-Cas12b detection platforms. [PDF]

Front Cell Infect Microbiol
Zhang Y, Lv L, Xu S, Chen Y.
europepmc   +1 more source

Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing

Molecular Oncology, EarlyView.
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef, Hana Barhom, Sumit Chatterji, Netta Hecht, Oran Warhaftig, Iris Kamer, Oranit Zadok, Jair Bar, Limor Broday, Amir Onn, Michael Peled   +10 more
wiley   +1 more source

Analysis and secure communication applications of a 4D chaotic system with transcendental nonlinearities. [PDF]

Sci Rep
Madani YA, Aldwoah K, Younis B, Alsharafi M, Osman O, Muflh B.   +5 more
europepmc   +1 more source

Trajectory sensitivity analysis on the equivalent one‐machine‐infinite‐bus of multi‐machine systems for preventive transient stability control

, 2014
Yan Xu, Zhao Yang Dong, Junhua Zhao, Yusheng Xue, David J. Hill   +4 more
openalex   +1 more source

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source

Assessing the efficiency of the bovine brucellosis surveillance-control system in a disease-free context through agent-based modelling. [PDF]

Vet Res
Mlala S, Picault S, Sala C, Villard P, Vinard JL, Hénaux V.   +5 more
europepmc   +1 more source